Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.49
+0.07 (0.94%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Precision BioSciences Employees
Precision BioSciences had 66 employees as of March 31, 2026. The number of employees decreased by 41 or -38.32% compared to the same quarter last year.
Employees
66
Change
-41
Growth
-38.32%
Revenue / Employee
$682,652
Profits / Employee
-$798,970
Market Cap
206.74M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 66 | -41 | -38.32% |
| Dec 31, 2025 | 68 | -40 | -37.04% |
| Sep 30, 2025 | 67 | -41 | -37.96% |
| Jun 30, 2025 | 102 | -8 | -7.27% |
| Mar 31, 2025 | 107 | -2 | -1.83% |
| Dec 31, 2024 | 108 | -1 | -0.92% |
| Sep 30, 2024 | 108 | -7 | -6.09% |
| Jun 30, 2024 | 110 | -82 | -42.71% |
| Mar 31, 2024 | 109 | -88 | -44.67% |
| Dec 31, 2023 | 109 | -89 | -44.95% |
| Sep 30, 2023 | 115 | -79 | -40.72% |
| Jun 30, 2023 | 192 | 0 | - |
| Mar 31, 2023 | 197 | 7 | 3.68% |
| Dec 31, 2022 | 198 | 0 | - |
| Sep 30, 2022 | 194 | -32 | -14.16% |
| Jun 30, 2022 | 192 | -44 | -18.64% |
| Mar 31, 2022 | 190 | -47 | -19.83% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Protalix BioTherapeutics | 226 |
| Voyager Therapeutics | 141 |
| Arcturus Therapeutics Holdings | 111 |
| Alector | 103 |
| Alpha Cognition | 71 |
| NovaBridge Biosciences | 30 |
| AN2 Therapeutics | 21 |
DTIL News
- 3 days ago - Precision BioSciences Earnings release: Q2 2026 - Filings
- 3 days ago - Precision BioSciences Quarterly report: Q2 2026 - Filings
- 4 days ago - Precision BioSciences reports Q2 EPS ($1.26) vs. ($2.13) last year - TheFly
- 4 days ago - Precision BioSciences sees cash runway through 2028 - TheFly
- 4 days ago - Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 10 days ago - Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026 - Business Wire
- 14 days ago - Precision BioSciences announces changes to its senior leadership team - TheFly
- 14 days ago - Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones - Business Wire